Responding to renewed interest in cancer vaccines, Merck & Co Inc and Moderna Therapeutics Inc have expanded a 2016 collaboration to develop and commercialise novel personalised messenger RNA (mRNA) vaccines. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
